BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15052992)

  • 1. Special report: evidence on sequencing of conventional and biological disease-modifying anti-rheumatic drugs.
    TEC Bull (Online); 2003 Nov; 20(3):24-9. PubMed ID: 15052992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 5. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials.
    Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S19-21. PubMed ID: 24129131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.
    Konttinen YT; Seitsalo S; Lehto M; Santavirta S
    Acta Orthop; 2005 Oct; 76(5):614-9. PubMed ID: 16263606
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based?
    Pincus T; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):1-4. PubMed ID: 17216670
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACR preliminary definition, of improvement in rheumatoid arthritis].
    Homma M
    Ryumachi; 1996 Dec; 36(6):891-900. PubMed ID: 9122830
    [No Abstract]   [Full Text] [Related]  

  • 12. [New strategies for treatment of rheumatoid arthritis].
    Kashiwazaki S
    Nihon Rinsho; 1997 Sep; 55(9):2467-75. PubMed ID: 9301317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New treatments in rheumatoid arthritis].
    Zarco Montejo P
    Rev Clin Esp; 1999 Jun; 199(6):337-9. PubMed ID: 10432805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disease modifying anti-rheumatic drugs (DMARDs): an overview].
    Kawabata D; Mimori T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():489-92. PubMed ID: 15799404
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in the treatment of early rheumatoid arthritis.
    Vital EM; Emery P
    Am Fam Physician; 2005 Sep; 72(6):1002, 1004. PubMed ID: 16190499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug delivery system of anti-inflammatory and anti-rheumatic drugs].
    Kawai S
    Nihon Rinsho; 1998 Mar; 56(3):782-7. PubMed ID: 9549373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheumatic ailments. Can arthritis drugs be tapered?].
    Füessl HS; Stiefelhagen P
    MMW Fortschr Med; 2015 Oct; 157(17):31. PubMed ID: 26759868
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2003 Jan; 1(5):25-32. PubMed ID: 15529103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.